Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).

Authors:
  • THT Hirano
    T Hirano
  • TTT Taga
    T Taga
  • NNN Nakano
    N Nakano
  • KYK Yasukawa
    K Yasukawa
  • SKS Kashiwamura
    S Kashiwamura
  • KSK Shimizu
    K Shimizu
  • KNK Nakajima
    K Nakajima
  • KPK H Pyun
    K H Pyun
  • TKT Kishimoto
    T Kishimoto

Abstract
Human B-cell differentiation factor (BCDF) was purified to homogeneity by sequential filtration and chromatography of culture supernatants from TCL-Na1 cells on an AcA34 gel column and then on a Mono P column with fast protein liquid chromatography and reversed-phase HPLC. A 5300-fold enrichment in specific activity of BCDF with about 25% recovery was attained. The homogeneity of purified BCDF was evidenced by the following: (i) the specific activity was 1.7 X 10(7) units/mg of protein, (ii) only two bands, Mr 19,000 and 21,000, were identified by NaDodSO4/PAGE under reduced as well as nonreduced conditions, and (iii) BCDF activity was recovered from the gel after NaDodSO4/PAGE in the fractions corresponding to protein bands of Mr 19,000 or 21,000. Purified BCDF induced Ig secretion in Epstein-Barr virus-transformed cell lines; as little as 3 pM gave 50% of the maximum reaction achieved by 30-80 pM BCDF. Purified BCDF induced Ig production in activated B cells without any effect on cell growth. Purified BCDF did not show any activity of interleukin 1 or 2, B-cell stimulatory factor (BSF)p-1, B-cell growth factor II (BCGF-II), or interferon. Since BCDF was isolated and characterized as described, we propose that the BCDF that induces the final differentiation of B cells into high-rate Ig-secreting cells be designated BSFp-2.

This publication has 34 references indexed in Scilit: